Arvind Sommi - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Arvind Sommi's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Arvind Sommi
Verified
Managing Editor, diaTribe
San Francisco
Beats
Fitness , Healthwellness , Mental , Health , Nutritionmedicine
everything else
Content
By Arvind Sommi Verified| diaTribe Verified Pfizer has provided an update on its oral GLP-1 medication danuglipron. If approved, danuglipron could be an additional option for people living with type 2 diabetes and obesity. Pfizer is moving forward with the clinical development of a new oral GLP-1 medicine called danuglipron for obesity and type 2 diabetes. Pfizer plans to further evaluate the safety and efficacy of the drug in clinical trials.
By Arvind Sommi Verified| diaTribe Verified Diabetic retinopathy is often preventable if caught early. Advancements in artificial intelligence and eye-scanning technology have made it possible for more people with diabetes to get evaluated for diabetic retinopathy. One in three people with diabetes has diabetic retinopathy, making it one of the most common diabetes complications. “It steals their joy, it steals their autonomy, and it deserves a solution,” said Dr. Robert Levine, chairman of the Mary Tyler Moore Vision Initiative.
By Arvind Sommi Verified| diaTribe Verified Pfizer has provided an update on its oral GLP-1 medication danuglipron. If approved, danuglipron could be an additional option for people living with type 2 diabetes and obesity. Pfizer is moving forward with the clinical development of a new oral GLP-1 medicine called danuglipron for obesity and type 2 diabetes. Pfizer plans to further evaluate the safety and efficacy of the drug in clinical trials.
Company Info
diaTribe
The diaTribe Foundation is a non-profit organization based in San Francisco, California, focused on improving the lives of individuals affected by diabetes and prediabetes. Founded by Kelly Close, the foundation aims to provide education, advocacy, and convening opportunities to help people manage their conditions effectively. The foundation offers free online educational resources through diaTribe Learn, which provides management tips and insights into the latest research and treatments. It also advocates for policy changes to enhance access to therapies and technologies, amplifying the voices of those with diabetes. Additionally, the diaTribe Foundation convenes stakeholders to address diabetes-related issues, including initiatives like The Time in Range Coalition and the dStigmatize program to combat stigma associated with diabetes. Led by CEO Jim Carroll, the diaTribe Foundation reaches over 6 million people annually, including individuals with diabetes, healthcare professionals, and policymakers. The organization emphasizes transparency and accountability in its operations.
'+1 415-241-9500
Founded: 2012